"Dr. Ajai Chari Outlines Disparities and Treatment Patterns in Multiple Myeloma"
Ajai Chari, MD, associate professor, hematology and medical oncology at the Icahn School of Medicine at Mount Sinai, discusses multiple myeloma. “Research has shown disparities in multiple myeloma treatment between clinical trials and real-world outcomes, as well as a lot of heterogeneity among treatment patterns by age and region.” He added, “The disparities relate to the differences between clinical trials and real-world outcomes. So, in clinical trials we cherry picked really healthy patients.”
— Ajai Chari, MD, Director, Clinical Research in the Multiple Myeloma Program, Associate Director, Clinical Research, Mount Sinai Cancer Clinical Trials Office, Associate Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
Mount Sinai Study Advances Understanding of Personalized Vaccines for Bladder Cancer
May 12, 2025 View All Press Releases
Mount Sinai Researchers Discover How Melanoma May Spread to the Brain
Apr 30, 2025 View All Press Releases
Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases
Mount Sinai Leads Phase 3 Trial in Myelofibrosis Treatment
Mar 19, 2025 View All Press Releases
Mount Sinai Researchers Discover Why Some Colon Cancers Resist Treatment
Feb 12, 2025 View All Press Releases
Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study
Jan 09, 2025 View All Press Releases
Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy
Jan 06, 2025 View All Press Releases